Dr. Sidney Gilman was the chair of the Department of Neurology at the University of Michigan from 1977 to 2004. In December 2012, he is cooperating with prosecutors over charges of insider trading based on advanced access to information about drug trials for the Alzheimer's drug Bapineuzumab.
In the news
http://annarborchronicle.com/2012/12/16/um-sidney-gilman/
http://blogs.wsj.com/law/2012/11/20/a-quick-guide-to-the-latest-insider-trading-case/
http://www.michigandaily.com/news/11umhs-emails-staff-about-insider-trading-scheme26